Bank of America’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
851,336
+177,556
| +26% | +$3.02M | ﹤0.01% | 2473 |
|
|
2025
Q1 | $13.2M | Buy |
673,780
+536,847
| +392% | +$10.5M | ﹤0.01% | 2463 |
|
|
2024
Q4 | $3.4M | Sell |
136,933
-403,054
| -75% | -$10M | ﹤0.01% | 3354 |
|
|
2024
Q3 | $13.2M | Buy |
539,987
+177,850
| +49% | +$4.36M | ﹤0.01% | 2408 |
|
|
2024
Q2 | $8.48M | Buy |
362,137
+41,085
| +13% | +$963K | ﹤0.01% | 2675 |
|
|
2024
Q1 | $10.6M | Buy |
321,052
+126,724
| +65% | +$4.19M | ﹤0.01% | 2505 |
|
|
2023
Q4 | $5.29M | Sell |
194,328
-172,389
| -47% | -$4.69M | ﹤0.01% | 2908 |
|
|
2023
Q3 | $8.82M | Buy |
366,717
+188,431
| +106% | +$4.53M | ﹤0.01% | 2398 |
|
|
2023
Q2 | $5.69M | Sell |
178,286
-199,334
| -53% | -$6.36M | ﹤0.01% | 2764 |
|
|
2023
Q1 | $11.6M | Buy |
377,620
+213,502
| +130% | +$6.54M | ﹤0.01% | 2297 |
|
|
2022
Q4 | $6.42M | Buy |
164,118
+44,343
| +37% | +$1.73M | ﹤0.01% | 2683 |
|
|
2022
Q3 | $5.71M | Sell |
119,775
-18,485
| -13% | -$880K | ﹤0.01% | 2709 |
|
|
2022
Q2 | $5.35M | Buy |
138,260
+547
| +0.4% | +$21.2K | ﹤0.01% | 2860 |
|
|
2022
Q1 | $7.89M | Buy |
137,713
+28,450
| +26% | +$1.63M | ﹤0.01% | 2692 |
|
|
2021
Q4 | $8.71M | Buy |
109,263
+91,841
| +527% | +$7.32M | ﹤0.01% | 2633 |
|
|
2021
Q3 | $1.52M | Buy |
17,422
+2,087
| +14% | +$181K | ﹤0.01% | 4013 |
|
|
2021
Q2 | $1.97M | Sell |
15,335
-4,605
| -23% | -$593K | ﹤0.01% | 3742 |
|
|
2021
Q1 | $1.6M | Buy |
19,940
+10,838
| +119% | +$867K | ﹤0.01% | 3916 |
|
|
2020
Q4 | $743K | Buy |
9,102
+4,590
| +102% | +$375K | ﹤0.01% | 4070 |
|
|
2020
Q3 | $111K | Sell |
4,512
-4,164
| -48% | -$102K | ﹤0.01% | 5017 |
|
|
2020
Q2 | $243K | Buy |
8,676
+2,154
| +33% | +$60.3K | ﹤0.01% | 4571 |
|
|
2020
Q1 | $117K | Buy |
+6,522
| New | +$117K | ﹤0.01% | 4842 |
|